Cargando…

Hyperoside suppresses BMP-7-dependent PI3K/AKT pathway in human hepatocellular carcinoma cells

BACKGROUND: New therapeutics for hepatocellular carcinoma (HCC) are urgently needed and searching for new anti-cancer compounds in plant medicines may represent a promising approach. The present study was conducted to clarify the role of hyperoside (HP) and its underlying molecular mechanism in a ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shuang, Sun, Yun, Wang, Li, Zhang, Tianfang, Hu, Wendi, Bao, Wangxiao, Mao, Lin, Chen, Jinxiu, Li, Haijun, Wen, Yankai, Chen, Zuobing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421975/ https://www.ncbi.nlm.nih.gov/pubmed/34532370 http://dx.doi.org/10.21037/atm-21-2980

Ejemplares similares

Review of rehabilitation protocols for brachial plexus injury
por: Li, Haijun, et al.
Publicado: (2023)

Early physical therapy for a patient affected by coronavirus disease 2019 (COVID-19) on awake veno-venous extracorporeal membrane oxygenation: a case report
por: Li, Haijun, et al.
Publicado: (2022)

Exercise Programs for Muscle Mass, Muscle Strength and Physical Performance in Older Adults with Sarcopenia: A Systematic Review and Meta-Analysis
por: Bao, Wangxiao, et al.
Publicado: (2020)

The Peripheral Immune System and Traumatic Brain Injury: Insight into the role of T-helper cells
por: Bao, Wangxiao, et al.
Publicado: (2021)

Metabolic Engineering of Escherichia coli for Hyperoside Biosynthesis
por: Li, Guosi, et al.
Publicado: (2022)

Preparation and Properties of Cyclodextrin Inclusion Complexes of Hyperoside
por: Zhang, Xinyu, et al.
Publicado: (2022)

Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice With Type 2 Diabetes Mellitus
por: Liu, Jialing, et al.
Publicado: (2021)

Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling
por: Zhou, Ya, et al.
Publicado: (2019)

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway
por: Chen, Houping, et al.
Publicado: (2021)

Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway
por: Shao, Hui, et al.
Publicado: (2023)

The parallel biosynthesis routes of hyperoside from naringenin in Hypericum monogynum
por: Wang, Yingying, et al.
Publicado: (2023)

Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Liao, Junbin, et al.
Publicado: (2019)

Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells
por: Hwang, HyunTae V., et al.
Publicado: (2018)

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
por: Huang, Jizhen, et al.
Publicado: (2020)

Pinocembrin Inhibits the Proliferation and Metastasis of Breast Cancer via Suppression of the PI3K/AKT Signaling Pathway
por: Zhu, Xinbing, et al.
Publicado: (2021)

Quality Analysis of Chlorogenic Acid and Hyperoside in Crataegi fructus
por: Weon, Jin Bae, et al.
Publicado: (2016)

CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling
por: Liu, Zhao, et al.
Publicado: (2018)

LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma
por: Peng, Chenghao, et al.
Publicado: (2021)

Hyperoside: A Review of Its Structure, Synthesis, Pharmacology, Pharmacokinetics and Toxicity
por: Xu, Sijin, et al.
Publicado: (2022)

Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway
por: Chen, Jiajia, et al.
Publicado: (2019)

PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF‐κB pathway
por: Mao, Misha, et al.
Publicado: (2019)

Hyperoside Attenuates Sepsis-Induced Acute Lung Injury (ALI) through Autophagy Regulation and Inflammation Suppression
por: Mai, Jingyin, et al.
Publicado: (2023)

Critical implication of the PTEN/PI3K/AKT pathway during BMP2-induced heterotopic ossification
por: Dong, Jun, et al.
Publicado: (2021)

Pan-Cancer Analysis Reveals That E1A Binding Protein p300 Mutations Increase Genome Instability and Antitumor Immunity
por: Chen, Zuobing, et al.
Publicado: (2021)

The spliceosome pathway activity correlates with reduced anti-tumor immunity and immunotherapy response, and unfavorable clinical outcomes in pan-cancer
por: Chen, Zuobing, et al.
Publicado: (2021)

Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways
por: Song, Jifu, et al.
Publicado: (2021)

Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway
por: Tan, Wenliang, et al.
Publicado: (2017)

Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1–42
por: Liu, Chen-Yang, et al.
Publicado: (2018)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: TIAN, FENG, et al.
Publicado: (2015)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

The Yunnan national medicine Maytenus compound inhibits the proliferation of hepatocellular carcinoma (HCC) by suppressing the activation of the EGFR-PI3K-AKT signaling pathway
por: Zhao, Wen-Tao, et al.
Publicado: (2021)

MST4 inhibits human hepatocellular carcinoma cell proliferation and induces cell cycle arrest via suppression of PI3K/AKT pathway
por: Hao, Wei-Chao, et al.
Publicado: (2020)

Hyperoside Induces Endogenous Antioxidant System to Alleviate Oxidative Stress
por: Park, Ji Young, et al.
Publicado: (2016)

TPX2 silencing exerts anti-tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway
por: Huang, Dan-Hong, et al.
Publicado: (2019)

Identification of COVID-19 subtypes based on immunogenomic profiling
por: Chen, Zuobing, et al.
Publicado: (2021)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer
por: Su, Wei, et al.
Publicado: (2016)

CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling
por: Xu, Gang, et al.
Publicado: (2017)

Dexamethasone inhibits BMP7-induced osteogenic differentiation in rat dental follicle cells via the PI3K/AKT/GSK-3β/β-catenin pathway
por: Tang, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0chn227bh0cctdkp89d9iqqs7q